The Platelet
Aggregation Devices Market Outlook and Analysis By
Product (Systems, Reagents, Consumables And Accessories), Application
(Clinical, Research Applications), End User (Hospitals And Clinics, Diagnostic
Laboratories, Others)- Forecast Till 2030
As per Market Research
Future (MRFR) analysis, the global platelet aggregation devices market held a
market value of USD 215.2 million in 2017 and is expected to grow at a CAGR of 21.50%
from 2022 to 2030 (forecast period).
Platelet
aggregation is a procedure in which human platelet cells are engaged in
hemostasis, restore bleeding, and closure of vessels. Platelet aggregation
plays a crucial function in inflammation and other pathological conditions. The
platelet aggregation test in the anti-coagulant medium requires venipuncture.
This is accompanied by centrifugation for platelet-rich plasma production,
which uses an aggregometer to analyze the aggregation of platelets.
Market Dynamics
Factors that
promote the growth of the demand for platelet aggregation devices are rising
older populations worldwide, combined with an increasing prevalence of target
diseases, a growing amount for industry-academia partnerships and clinical
studies, and a rise in platelet aggregometer technology.
Nonetheless, the
existence of unfavorable health reforms in the US and operational constraints
are projected to curb demand growth over the forecast period. The World Health
Organization (WHO) reported that the global population aged 60 years and over
was 962.0 million in 2017, which is expected to increase to more than 2.0
billion by 2050 and to reach 3.1 billion by 2100.
Segmentation
The global platelet
aggregation devices market share has been segmented
into product, application, and end-user.
By product, the
global market for platelet aggregation devices has been segmented into systems,
reagents, and consumables and accessories. In 2017, the systems segment dominated
the market due to continuous technological advancements in sensors and
detectors, increasing automation of platelet aggregation testing procedures,
and growing adoption and market preference for automated instruments among
diagnostic laboratories
Based on the
application, the market has been divided into clinical applications and
research applications. The clinical applications segment is further divided
into cardiovascular applications, orthopedic applications, and others.
Based on end-user,
the global market for platelet aggregation devices has been categorized into
hospitals and clinics, diagnostic laboratories, research and academic
institutes, and others.
Regional Analysis
Regionally, the
global platelet aggregation devices market share has been segmented into the
Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas
dominated the global market for platelet aggregation devices due to the
presence of device manufacturers, a growing number of surgical procedures,
increasing awareness among healthcare professionals (HCPs) about the benefits
of platelet aggregation testing in the diagnosis of disease, and substantial
investments in R&D activities using platelets. For example, as per the
National Center for Health Statistics, around 48.0 million surgical inpatient
procedures were conducted in the United States in 2009, which rose to 1.54
million by the end of 2017.
The availability of
inexpensive platelet function tests and expanding distribution networks, a
growing number of cardiovascular surgeries, new technical advances in platelet
aggregators, and an increase in the number of clinical trials in the United
Kingdom, Germany, and France are expected to sustain Europe's second-largest
position on the global market. For example, according to data published by the
European Medicines Agency (EMA) and the British Medical Journal, nearly 4,000
clinical trials of medicinal products are approved annually in the European
Union (EU).
The Asia Pacific
market would see the fastest growth during the forecast period ascribed to an
increasing geriatric population coupled with a rising prevalence of chronic
diseases, an increase in the adoption of new technological devices, and an
increase in the incidence of mosquito-borne diseases, namely malaria, and
dengue. Severe dengue is the leading cause of severe illness and death among
children in some Asian and Latin American countries as per the World Health
Organization. More than 40.0% of the world's population is at risk of dengue
infection in more than 100 countries. The most serious dengue epidemics in
recent years have reported in South East Asia, the Americas, and the Western
Pacific. An approximate 390.0 million dengue infections occur worldwide every
year.
The market for
platelet aggregation devices in the Middle East and Africa are expected to have
a modest market growth rate from 2018 and 2023 due to the adoption of new
technologies, increasing prevalence of hemophilia disease, improving healthcare
infrastructure and expanding market by various market players in the Gulf
Cooperation Council ( GCC) countries, Israel and South Africa.
Key Players
Some of the major
participants in the global platelet aggregation devices market share are
Siemens Healthineers, Hoffmann-La Roche Ltd, Haemonetics Corporation, Sysmex
Corporation, Werfen, Helena Laboratories, Bio/Data Corporation, AggreDyne,
Inc., Sentinel CH. SpA, Haemochrom Diagnostica GmbH, Pathway Diagnostics
Limited.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment